Literature DB >> 15860516

Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease.

Frans H Rutten1, Maarten-Jan M Cramer, Diederick E Grobbee, Alfred P E Sachs, Johannes H Kirkels, Jan-Willem J Lammers, Arno W Hoes.   

Abstract

AIMS: To establish the prevalence of unrecognized heart failure in elderly patients with a diagnosis of chronic obstructive pulmonary disease, in a stable phase of their disease. METHODS AND
RESULTS: In a cross-sectional study, patients >/=65 years of age, classified as having chronic obstructive pulmonary disease by their general practitioner and not known with a cardiologist-confirmed diagnosis of heart failure, were invited to our out-patient clinic. Four hundred and five participants underwent an extensive diagnostic work-up, including medical history and physical examination, followed by chest radiography, electrocardiography, echocardiography, and pulmonary function tests. As reference (i.e. 'gold') standard the consensus opinion of an expert panel was used. The panel based the diagnosis of heart failure on all available results from the diagnostic assessment, guided by the diagnostic principles of the European Society of Cardiology (ESC) for heart failure (i.e., symptoms and echocardiographic systolic and/or diastolic dysfunction). The diagnosis of chronic obstructive pulmonary disease was based on the diagnostic criteria of the Global Initiative (GOLD) for chronic obstructive pulmonary disease. Of 405 participating patients with a diagnosis of chronic obstructive pulmonary disease, 83 (20.5%, 95% CI 16.7-24.8) had previously unrecognized heart failure (42 patients systolic, 41 'isolated' diastolic, and none right-sided heart failure). In total, 244 (60.2%) patients had chronic obstructive pulmonary disease according to the GOLD criteria and 50 (20.5%, 95% CI 15.6-26.1) patients combined with unrecognized heart failure.
CONCLUSION: Unrecognized heart failure is very common in elderly patients with stable chronic obstructive pulmonary disease. Closer co-operation among general practitioners, pulmonologists, and cardiologists is necessary to improve detection and adequate treatment of heart failure in this large patient population.

Entities:  

Mesh:

Year:  2005        PMID: 15860516     DOI: 10.1093/eurheartj/ehi291

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  112 in total

Review 1.  Administrative data have high variation in validity for recording heart failure.

Authors:  Susan Quach; Claudia Blais; Hude Quan
Journal:  Can J Cardiol       Date:  2010-10       Impact factor: 5.223

Review 2.  Clinical epidemiology of heart failure.

Authors:  Arend Mosterd; Arno W Hoes
Journal:  Heart       Date:  2007-09       Impact factor: 5.994

Review 3.  [Pulmonary diseases and heart function].

Authors:  K Rasche; M Orth; A Kutscha; H W Duchna
Journal:  Internist (Berl)       Date:  2007-03       Impact factor: 0.743

4.  Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community.

Authors:  Carolyn S P Lam; Asya Lyass; Elisabeth Kraigher-Krainer; Joseph M Massaro; Douglas S Lee; Jennifer E Ho; Daniel Levy; Margaret M Redfield; Burkert M Pieske; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Circulation       Date:  2011-06-13       Impact factor: 29.690

Review 5.  Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence.

Authors:  Gülmisal Güder; Frans H Rutten
Journal:  Curr Heart Fail Rep       Date:  2014-09

6.  Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Sunil K Agarwal; Gerardo Heiss; R Graham Barr; Patricia P Chang; Laura R Loehr; Lloyd E Chambless; Eyal Shahar; Dalane W Kitzman; Wayne D Rosamond
Journal:  Eur J Heart Fail       Date:  2012-02-25       Impact factor: 15.534

7.  Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study.

Authors:  Benjamin M Smith; Steven M Kawut; David A Bluemke; Robert C Basner; Antoinette S Gomes; Eric Hoffman; Ravi Kalhan; João A C Lima; Chia-Ying Liu; Erin D Michos; Martin R Prince; LeRoy Rabbani; Daniel Rabinowitz; Daichi Shimbo; Steven Shea; R Graham Barr
Journal:  Circulation       Date:  2013-03-14       Impact factor: 29.690

8.  Early recognition of heart failure in patients with diabetes type 2 in primary care. A prospective diagnostic efficiency study. (UHFO-DM2).

Authors:  Leandra J M Boonman-de Winter; Frans H Rutten; Maarten J Cramer; Anho H Liem; Marcel J Landman; Henk F van Stel; G Ardine de Wit; Guy E H M Rutten; Paulien A W van Hessen; Arno W Hoes
Journal:  BMC Public Health       Date:  2009-12-21       Impact factor: 3.295

Review 9.  Nebulized formoterol: a review of clinical efficacy and safety in COPD.

Authors:  Nicholas J Gross; James F Donohue
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-08-09

Review 10.  Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.

Authors:  Jon O Ebbert; Kirk D Wyatt; Ali Zirakzadeh; Michael V Burke; Jt Hays
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.